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Newborn screening programs for severe metabolic disorders using tandemmass spectrometry are widely
used. Medium-Chain Acyl-CoA dehydrogenase deﬁciency (MCADD) is the most prevalent mitochondrial
fatty acid oxidation defect (1:15,000 newborns) and it has been proven that early detection of this met-
abolic disease decreases mortality and improves the outcome. In previous studies, data mining methods
on derivatized tandem MS datasets have shown high classiﬁcation accuracies. However, no machine
learning methods currently have been applied to datasets based on non-derivatized screening methods.
A dataset with 44,159 blood samples was collected using a non-derivatized screening method as part of
a systematic newborn screening by the PCMA screening center (Belgium). Twelve MCADD cases were
present in this partially MCADD-enriched dataset. We extended three data mining methods, namely
C4.5 decision trees, logistic regression and ridge logistic regression, with a parameter and threshold opti-
mization method and evaluated their applicability as a diagnostic support tool. Within a stratiﬁed cross-
validation setting, a grid search was performed for each model for a wide range of model parameters,
included variables and classiﬁcation thresholds.
The best performing model used ridge logistic regression and achieved a sensitivity of 100%, a speciﬁc-
ity of 99.987% and a positive predictive value of 32% (recalibrated for a real population), obtained in a
stratiﬁed cross-validation setting. These results were further validated on an independent test set. Using
a method that combines ridge logistic regression with variable selection and threshold optimization, a
signiﬁcantly improved performance was achieved compared to the current state-of-the-art for deriva-
tized data, while retaining more interpretability and requiring less variables. The results indicate the
potential value of data mining methods as a diagnostic support tool.
 2010 Elsevier Inc. All rights reserved.1. Introduction
The early diagnosis of rare diseases constitutes a great challenge
in current medicine. Currently rare diseases are often diagnosed
too late, resulting in a decline in life expectancy and quality of life,
and an increase in healthcare costs. The large variety of rare dis-
eases makes that – although each disease affects only a small num-
ber of people – it still affects a large population. As such, the total
number of patients suffering from a rare disease in Europe isll rights reserved.
den Bulcke).around 30 million [1]. Early detection and diagnosis of metabolic
disorders and of rare diseases in general, are of crucial importance
for the further outcome of the patient. As such, statistical and
machine learning methods could be of great value as a diagnostic
support tool for doctors and medical personnel.1.1. MCADD
This study focuses on MCADD (Medium-Chain Acyl-CoA dehy-
drogenase deﬁciency), the most frequent metabolic disorder of
mitochondrial fatty acid oxidation [2]. There are four categories
of fatty acids, differentiated by their carbon chain length: short
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enzymes responsible for their b-oxidation are respectively SCAD,
MCAD, LCAD and VLCAD (small, medium, long and very long chain
acyl-Co-A dehydrogenase).
Our body preferentially metabolizes carbohydrates, but only a
limited stock of carbohydrates is available and after a fasting per-
iod of 9–10 h (e.g. a normal night of sleep), the body switches to
energy production from fatty acids. Defects of mitochondrial fatty
acid b-oxidation therefore lead to a disturbed or inhibited energy
production of fatty acids. Inherited defects fall into three groups:
(a) those associated with the carnitine mediated transport into
the mitochondria; (b) those of the matrix enzymes (such as
MCAD); and (c) those affecting the activity of membrane-bound
enzymes of long-chain fatty acid oxidation.
In case of MCADD, the production of the MCAD enzyme is ab-
sent or reduced. As such, the b-oxidation of the fatty acids C4
and higher fails and they can subsequently not be used as an en-
ergy source. The symptomatic MCADD-patient shows a clinical pic-
ture strongly resembling Reye’s syndrome with hepatomegaly and
stupor associated with hypoketonemia, hypoglycemia, hypocarn-
itinemia, increased transaminsase and mild hyperammonemia
[3]. Lipids that cannot be used precipitate in liver, heart, kidneys.
These patients present themselves over the years with hepatomeg-
aly or hepatic steatosis, cardiomyopathy, encephalopathy and
decreased muscle tone. 10–20% of the patients develop rhabdomy-
olysis in the ﬁrst three years of life, even when adequately
treated [4].
The early diagnosis of MCADD – and metabolic diseases in gen-
eral – is crucial for the further outcome and prognosis of the pa-
tient. If the diagnosis is made early, the quality of life can be
substantially improved. With supplementation of acylcarnitine
and a diet high in carbohydrates and low in fats and fasting periods
not longer than 6 h, the prognosis for the MCADD patient is very
favorable [4]. Through early diagnosis of MCADD, the risk of death
during derailment reduces to zero and the neurological rest lesions
(epilepsy, paralysis, behavioral disorders, developmental disor-
ders) after decompensation are halved [4]. There is thus an
important role for preventive medicine where a metabolic disease
is transformed into a metabolic disorder by means of simple
measures (prevention of fasting and rapid care of sober states) that
prevent the development of the disease. These children should be
followed in the ﬁrst 5–7 years of life to avoid decompensation. This
can be done by the general practitioner and does not require a
specialized center.1.2. MCADD screening
MCADD in infants can be detected via a blood sample which is
taken within a few days after birth using a heel prick test. The heel
prick is performed systematically for all newborns in many devel-
oped countries (e.g. Denmark, The Netherlands, Germany, Belgium
and Luxembourg). The blood sample is subsequently analyzed
using tandemmass spectrometry. Depending on the screening cen-
ter, a derivatized [5] or non-derivatized [6] screening method is
used. A sample spectrum is shown in Fig. 1 for both a normal
and an MCAD-deﬁcient person.
An increase of the speciﬁc acylcarnitine values above estab-
lished (device-speciﬁc) cut-off points usually results in a second
blood analysis, carried out when the child is 8 weeks old. This
second analysis includes the determination of acylcarnitine values
– with tandem mass spectrometry – and the fatty acid proﬁle in
plasma. Then the organic acids and glycines in urine are deter-
mined [7]. If this second test shows no normalization of the
acylcarnitine values, there is need for further review by enzymatic
studies and/or DNA analysis.Many screening centers currently use a derivatized screening
method [5]. However, the PCMA as well as some other screening
centers in Europe, have switched to using a non-derivatized
screening method [6]. The key difference is that the derivatizaton
step which requires heating of the dried analytes with dry,
acidiﬁed (3 N) butanol, is no longer needed. The non-derivatized
method requires less processing steps, leads to faster extraction
times and has a lower cost for reagents [8].
While both methods show strong correlation among the differ-
ent measured analytes, it was reported that several analytes
showed consistent bias (C0, C2, C10, C16, Gly and Arg) for the
non-derivatized method compared to the derivatized method [9].
For four instances this bias was due to higher recovery (C2, C10,
C16 and Arg) and for the two others (C0 and Gly) this was due to
a lower recovery. This bias can potentially affect the performance
of data mining algorithms and may also lead to slightly different
models or model parameters compared to models for derivatized
data.1.3. Data mining methods for MCADD classiﬁcation
Several statistical techniques have been published to establish
cutoff values on acylcarnitine values for MCADD classiﬁcation
[10–13]. A comparison of different data mining algorithms for clas-
siﬁcation of MCADD and other metabolic disorders on derivatized
tandem MS neonatal data was done by Baumgartner et al.
[14,15]. A feature selection approach for MCADD classiﬁcation by
Ho et al. [16] can be considered as the current state-of-the art data
mining method with respect to performance. They reported sensi-
tivity and speciﬁcity values of 100% and 99.901% respectively on a
dataset of derivatized tandem MS neonatal data in Heidelberg.
This study is the ﬁrst application of machine learning tech-
niques on non-derivatized neonatal screening data. We applied
C4.5 decision trees, logistic regression and ridge logistic regression
using a grid search approach to optimize model parameter settings,
included variables and classiﬁcation thresholds. Our results using
ridge logistic regression show a signiﬁcantly better performance
compared to the current state-of-the-art method for derivatized
MS data [16] while our method requires less variable measure-
ments and retains more interpretability.2. Materials and methods
2.1. Dataset
An anonymized dataset of 44,159 blood samples was collected
and analyzed using a non-derivatized tandem MS screening meth-
od [6] containing 12 MCADD cases. The dataset consists of two sep-
arate parts, each measured using a different screening system.
The ﬁrst part is used as training data for learning the classiﬁca-
tion models. It was obtained as part of a systematic screening for
newborns by the PCMA screening center (Belgium) during the ﬁrst
half of 2009. It consists of 32,109 samples and was collected using
the Quattro micro screening system. This dataset was further en-
riched with blood samples of all MCADD cases that occurred be-
tween 2003 and 2009 at the PCMA screening center, resulting in
a total of 9 MCADD samples. These 9 MCADD cases were further
conﬁrmed with a genetic test and to our best knowledge, no
unidentiﬁed MCADD cases are present in the dataset.
The second part of the dataset is used as an independent test set.
It was analyzed using a different screening system (Xevo QT MS)
and consists of 12,050 samples (collected between June 2010 and
September 2010). This dataset contained no MCADD cases from
the general population and has been enriched with three spiked
blood samples that were provided by the Centre for Disease
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Fig. 1. Tandem MS spectrum for a normal (upper) vs. MCAD deﬁcient (lower) blood sample.
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designed to resemble a real MCADD blood sample and any screen-
ing center should identify them as positive MCADD cases. While
some quantitative differences exist between the CDC samples
and real MCADD cases, the most relevant acylcarnitine measure-
ments are comparable. Both sets can therefore be considered sufﬁ-
ciently similar for the presented analyses in this study. We refer to
Supplementary File 1 for a detailed comparison between the CDC
control samples and real MCADD samples.
The measured parameters for each blood sample are the fatty
acid concentrations C0, C3, C5, C5DC, C6, C8, C10, C10:1, C14:1,
C16 and concentration ratio’s C3/C2, C5DC/C8, C5DC/C16, C8/C2,
C8/C10, C8/C12. These measures were further enriched with all
possible derived ratios for combinations of the primary concentra-
tions, such as C0/C6, C8/C16, leading to 45 additional variables. All
concentrations and ratio’s were log10-transformed for the analysis,
leading to approximate normal distributions with heavy tails for
the concentrations. These measured parameters are the predictor
variables and are denoted as X, the binary outcome is denoted as
MCADD (0 = no MCADD; 1 = MCADD).
2.2. Machine learning methods
Three data mining methods were compared: decision trees, lo-
gistic regression and ridge logistic regression. For each of these
methods, models were constructed starting from various subsets
of the original and derived variables, as shown in Table 1.
In decision trees, a (usually binary) classiﬁcation tree is con-
structed and a class is assigned to each leaf node. In each internal
node, a simple decision rule – usually involving a single variable
that is above or below a speciﬁc threshold – decides for taking
the left or right branch. A decision tree is usually learned from
the data by iteratively splitting nodes into child nodes by means
of a splitting criterion that maximizes information gain or some
other measure that tends to separate the two classes into separate
nodes. Decision trees can be overﬁtted to the data and are there-
fore usually pruned (i.e. some branches are removed from the tree).
One of the most well known and often used algorithms is C4.5 [17],
which is used in our experiments.
Binary logistic regression [18] is a widely used statistical tech-
nique that constructs a hyperplane between two datasets which
separates the two classes. The risk or probability for having
MCADD is deﬁned by Eq. (1), where z is deﬁned as a linear functionof its predictors x (Eq. (2)). For performing a classiﬁcation, a cutoff
for the probability f(z) is often set at 0.5. In our experimental setup
however, this cutoff is also optimized.
PðMCADD ¼ truejX ¼ xÞ ¼ f ðzÞ ¼ e
z
ez þ 1 ð1Þ
Z ¼ b0 þ b1x1 þ b2x2 þ b3x3 þ . . . þþbkxk ð2Þ
Ridge logistic regression [19] extends logistic regression by introduc-
ing an additional ridge parameter k in the model. An additional pen-
alty term, k||b||2, is added to the log-likelihood where b is the vector
of the regression coefﬁcients. For k = 0, the model behaves as logis-
tic regression. For larger values of k, larger model coefﬁcients are
penalized and generally tend to be closer to 0. As such, the model
coefﬁcients are somewhat biased, whereas the coefﬁcients obtained
with normal logistic regression are unbiased estimators of the true
coefﬁcients. When the predictor variables are collinear or near col-
linear, the variances of these coefﬁcients are however much smaller
than for logistic regression and the overall error for ridge logistic
regression will therefore be lower (see also ‘bias-variance tradeoff’
in [20]).
2.3. Experimental setup
The overall experimental setup is shown in pseudo code in Ta-
ble 2 and is deﬁned as follows. We evaluated three data mining
methods (decision trees, logistic regression and ridge logistic
regression) for a range of model parameters (such as the ridge
parameter for the regression, the conﬁdence threshold for pruning
in decision trees etc.) and for different subsets of variables that
were included in the model (Table 1).
For each of the combinations model/variable set, an N-fold
stratiﬁed cross-validation was performed where N is the number
of MCADD cases in the dataset. A regular cross-validation would
result in an uneven balancing of the MCADD cases over the differ-
ent folds, therefore a stratiﬁed N-fold cross-validation was used,
resulting in 1 MCADD case for each fold. This procedure was re-
peated 10 times for different randomizations of the dataset and
the results were averaged.
While the main output of the classiﬁcation algorithms is usually
a binary classiﬁcation (0 = no MCADD; 1 = MCADD), we will use the
probability of being classiﬁed as MCADD as the primary output of
the algorithm. This enables us to further improve the performance
by choosing an optimal probability threshold value (within the
Table 1
Selected subsets of variables that were evaluated for each of the models and
parameter settings. Set 1 includes all measured concentrations and ratios that are
used in the newborn screening at the PCMA screening center. Set 2 extends this set by
also calculating all other possible ratios between these concentrations and adding
them to the variable list. Set 3 includes only measured concentrations, without any
ratios. Sets 4–20 include various subsets of variables that are associated with MCADD.
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MCADD cases are correctly identiﬁed while keeping the number
of false positives minimal.
A straightforward choice of this threshold would be to select the
threshold value where all MCADD cases in the training set are iden-
tiﬁed as positive and the number of false positives in the training
set is minimal, called thresholdTRAIN. This threshold value is how-
ever likely to be too conservative and will fail to identify some
MCADD cases in the test set. In order to accommodate for this, an
adjustment factor is deﬁned that introduces an additional margin
on this threshold, which is illustrated in Fig. 2. All predicted prob-
abilities P(MCADD = true|X = x) are sorted and thresholdTRAIN is the
probability threshold value such that all actual MCADD cases are
equal or above this threshold. We deﬁne K as the total number of
cases that is equal or above this threshold. This index K is multi-
plied with an adjustment factor FADJ, leading to a new threshold
thresholdOPT. This is the (FADJ  K)th element in the sorted
P(MCADD = true|X = x) vector, where (FADJ  K) is rounded to the
nearest integer.
The following performance measures were used to evaluate the
models: sensitivity = TP/(TP + FN), speciﬁcity = TN/(TN + FP) and posi-
tive predictive value (PPV) = TP/(TP + FP) where TP indicates the
number of true positives, TN the number of true negatives, FP the
number of false positives and FN the number of false negatives.
As explained below, calculations of PPV were corrected for the true
MCADD prevalence.3. Results
The models were evaluated for a broad range of adjustment fac-
tors (0.5–5) and model parameter settings. The best models to-
gether with their associated parameter settings are shown in
Table 3. Model A is the best decision tree model; model B shows
the best model for logistic regression with only C8 as a predictor
variable; model C is the best model with logistic regression for
all possible variable sets; and model D is the overall best model,
namely a ridge logistic regression model.Previously reported performance measures for MCADD predic-
tion (Baumgartner et al. [14]); Ho et al. [16]) do not accurately re-
ﬂect the expected performance on datasets of real populations:
both studies calculate performances on datasets which are en-
riched with MCADD cases (or which are depleted with non-
MCADD cases), leading to highly biased performance measures
such as the positive predictive value (PPV). The PPV was therefore
recalculated to assess how many false positives we would encoun-
ter in a real population. In order to allow a fair comparison, an
MCADD prevalence of 1/15,000 is used for all studies to recalculate
the PPV. Because the training data was highly enriched for MCADD
cases, the calculated PPV values for a real population are signiﬁ-
cantly different from the reported PPV values in the respective
publications. Since the dataset enrichment has no effect on sensi-
tivity and speciﬁcity measures, no recalculation of these measures
was required. The performance measures shown in Table 3 are de-
rived from the cross-validation analysis on the training data in the
respective studies. The reason is that both studies included part of
the training data in their test sets and the reported results may
therefore be slightly too optimistic for the test data. Using the
training data and recalibrating the results more accurately reﬂects
the true expected performance.3.1. Decision tree models
Firstly, a number of decision tree models were evaluated. The
best performing decision tree model was model A, which achieves
high sensitivity (98.889%) but does not identify all MCADD cases
in a cross-validation setting. The selected variables in the model
were C8, C10 and C8/C2, which are known to be indicative for
MCADD. The decision tree model of Baumgartner et al. [14], model
E, also included C8 and C10 but excluded the C8/C2 ratio in favor of
the C16 concentration. The PPV of our best model (19.21%) is sig-
niﬁcantly higher than the current state of the art decision tree
model [14] (1.30%). The differences in performance (PPV) between
our method and current state-of-the-art could be either due to the
nature of the dataset, due to the different methodology or a com-
bination of both (see Section 4). From a medical perspective, still
an unacceptably high number of MCADD patients are diagnosed
as healthy using the decision tree method (>1%). Decision trees
were also less robust w.r.t. variations in parameter settings and
variable selection choices, leading to larger variations in sensitivity
and speciﬁcity compared to logistic regression for the range of
evaluated models (results not shown). These two undesired prop-
erties make decision trees less appropriate choices for modeling
MCADD.3.2. Logistic regression analysis using only C8
Secondly, a series of logistic regression analyses were per-
formed with one single parameter C8, the predominant metabolite
associated with MCADD. The best model, namelymodel B (Table 3),
resulted in good predictions: 100% of the MCADD cases were iden-
tiﬁed in the cross-validation setting with an average speciﬁcity of
99.965% over the different randomizations. Comparing the results
with a normal logistic regression (without threshold optimization)
for the same dataset (model H), we see that our threshold optimi-
zation strategy increases sensitivity from 62.5% to 100%, while
decreasing the PPV (22.9–15.9%) and speciﬁcity (99.988–
99.965%). This result conﬁrms that statistical models that only
use C8 as a predictor can already achieve a high classiﬁcation
accuracy [14]. This is also illustrated in Fig. 3 which shows the
log-concentration of C8 for MCADD (red diamonds) and normal
(black dots) cases.
Table 2
Pseudo code of the experimental setup.
for each data mining method M:
for each set of model parameters P:
for each set of variables V:
for each randomization R:
for each cross-validation-fold F:
testData = rowSubset(dataset, select = fold F, rand = R)
trainDataAllColumns = rowSubset(dataset, select = all except fold F, rand = R)
trainData = colSubset(trainDataAllColumns, V)
model = train(M, trainData)
trainProbabilities[F] = predict(model, trainData)
thresholdTrain = calcThresholdTrain(trainProbabilities[F], trainData)
testProbabilities[F] = predict(model, testData)
for each adjustment factor FADJ:
measures[M, P, V, R, F, FADJ] = calcMeasures(testProbabilities, FADJ  thresholdTRAIN)
measuresAggr = aggregate(measures, F, type = sum) # sum the results overall CV-folds
measuresAvg = aggregate(measuresAggr, R, type = mean) # average over the different randomizations
modelA = select (M, P, V, FADJ) for which
measuresAvg[k].M() = = ‘‘C4.5’’ and
measuresAvg.speciﬁcity() is maximal and
measuresAvg.sensitivity() = = max(measuresAvg[M = ’’C4.5’’].sensitivity())
modelB = select (M, P, V, FADJ) from measuresAvg[k] for which
measuresAvg[k].speciﬁcity() is maximal and
measuresAvg[k].sensitivity() = = max(measuresAvg[M = ’’Logistic’’, P = ‘‘k = 0’’, V = ’’C8’’].sensitivity())
modelC = select (M, P, V, FADJ) from measuresAvg[k] for which
measuresAvg[k].M() = = ‘‘Logistic’’ and measuresAvg[k].P() = = ‘‘k = 0’’ and
measuresAvg[k].speciﬁcity() is maximal and
measuresAvg[k].sensitivity() = = max(measuresAvg[M = ’’Logistic’’, P = ‘‘k = 0’’].sensitivity())
modelD = bestModel = select (M, P, V, FADJ) from measuresAvg[k] for which
measuresAvg[k].speciﬁcity() is maximal and
measuresAvg[k].sensitivity() = = max(measuresAvg.sensitivity())
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The positive predictive value and speciﬁcity can be further
increased by including more variables in the regression model
without reducing the sensitivity. The best performing logistic
regression model for all of the variable sets (without using ridge
regression), is model C (Table 3). A number of additional variables
to C8 are included, namely C8/C2, C6/C8, C6/C10 and C8/C10, that
are known to be predictive for MCADD [16]. By including these
variables, the (recalibrated) PPV is increased from 15.92% to
23.41% while retaining 100% sensitivity.3.4. Ridge logistic regression
The overall best model, namely model D, uses ridge logistic
regression [19] and includes the same set of variables as model C.
Compared to logistic regression, the recalibrated PPV was further
increased to 33.90% while the sensitivity remained at 100%, there-
by outperforming the current state-of-the-art methods on deriva-
tized datasets. The PPV for our independent test dataset (28.67%)
conﬁrms that this high performance is not due to overﬁtting. By
using ridge regression, the contribution of less predictive variables
and highly correlated variables in the model are reduced, thereby
reducing overﬁtting of the model.4. Discussion
In this study, the performance of a number of data mining
methods were compared for predicting MCADD classiﬁcation
based on acylcarnitine measurements. In situations where there
is a large asymmetry between misclassifying a positive vs. a nega-
tive sample, cost-based classiﬁers [21] are frequently used which
optimize a loss function rather than minimizing the overall mis-
classiﬁcation rate. While this approach is certainly applicable, it
was not used in this study. Rather we have chosen to directly opti-mize the probability cutoff, which is more directly linked to our
goal of maximizing the sensitivity.
The current state of the art method for the derivatized screening
method was developed by Ho et al. [16] and is shown as model F in
Table 3. The model by Ho et al. that is based on derivatized screen-
ing data (model E, Table 3) uses seven different variables, namely
C4, C5:1, C8, C10, C14OH, C16OH and C18:1. While the model
achieves 100% sensitivity, the expected positive predictive value
for a real population is low (6.3%). The model uses complex fea-
tures to classify MCADD, as shown in Eq. (3), and is therefore
slightly more difﬁcult to interpret. The best performing model in
our analysis requires less variable measurements, namely 5, and
achieves a strongly improved performance (sensitivity = 100%;
PPV = 33.90%).
ðC8 C4þ C5 : 1þ C10Þ > 0:004 and C8þ C18 : 1
C14OHþ C16OH
> 2:012 ð3Þ
As stated, there are quantitative differences between the measure-
ments for the derivatized screening and non-derivatized screening
methods which may affect the performance of the data mining
methods. The differences in performance (PPV) between our meth-
od and current state-of-the-art could be due to the nature of the
dataset (non-derivatized), due to the different methodology or
due to a combination of both. It is difﬁcult to answer this question
conclusively. We do observe that our threshold optimization meth-
od strongly improves performance of logistic regression on the
same non-derivatized dataset (Table 3, model H vs. model B). This
indicates that at least part of the performance difference between
our models and current state-of-the-art on derivatized datasets
can be explained due to our methodology.
Some remarks are necessary regarding the optimal value for the
adjustment factor FADJ. Because we have only a small sample (nine
cases) of the full distribution of MCADD cases, we do not have suf-
ﬁcient measurements from the tails of this full distribution. Our
Fig. 2. Illustration of the calculation of the adjusted threshold thresholdADJ.
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expected sensitivity of the dataset but it does not account for the
variance on this estimate. This implies that, while the estimate on
the sensitivity is 100%, the real sensitivity may deviate from this
number. As such, an analysis on a larger dataset may lead to a low-
er speciﬁcity or sensitivity. Unfortunately, due to the small number
of MCADD samples, a standard deviation on this estimate cannot
be reliably estimated. In order to use these models in practice,
either a larger dataset is required with more MCADD cases to train
the model or an additional safety margin for the adjustment factor
can be chosen.
Our approach of threshold optimization in combination with
ridge logistic regression leads to very stable performances, inde-
pendent of the exact value of ridge regression coefﬁcient k for a
broad range of values. The reason for this behavior is likely because
of the threshold optimization method that compensates anyTable 3
Performance measures for the best performing models. The best performing models are sho
(no ridge) with only C8 (B); the best logistic regression model (no ridge) (C); and the ove
the variables that were selected by the model. For models A–D the original variable set that
sensitivity, speciﬁcity and positive predictive value indicate the performance in a cross-val
column cohort size reﬂects the total size of the dataset, while training data shows the actual
of MCADD cases for both columns). The bold PPV values are derived from cross-validation a
For reference, the models of Baumgartner et al. [14] and Ho et al. [16] are shown as curren
(G) methods, based on derivatized tandem MS data. Model H shows the results for a norma
the PCMA. Note that the reported numbers of models E–G are not directly comparabl
abbreviations: PT: conﬁdence threshold for pruning [17], M: minimal number of instances
⁄The reported positive predictive value (PPV) is adjusted for the enrichment in the dataset
of 1/15,000. Note that sensitivity and speciﬁcity are identical for enriched and normal dchange in predicted probabilities by adjusting the optimal thresh-
old value. In general, ridge logistic regression combined with
threshold optimization has desirable properties for practical appli-
cations. Firstly, it leads to an interpretable model since a (logistic)
regression model is used. Secondly, the performance is stable w.r.t.
large variations in parameter settings. Thirdly, the adjustment fac-
tor can easily be interpreted and adjusted by a domain expert, e.g.
to be more conservative than strictly required.
Currently, one of the main difﬁculties in modeling MCADD and
other metabolic disorders, is that these models cannot be directly
used by other screening centers due to variation between
screening centers in equipment and sample preparation. Moreover,
each new batch of sampling kits in a screening center requires a
recalibration of the experimental setup. It would be desirable, both
from a medical and data mining perspective, to establish a gold
standard across screening centers that enables a universal calibra-
tion of the screening results, both for non-derivatized and deriva-
tized methods. This would ensure the direct interchangeability of
statistical models and would also allow researchers to combine
datasets from different screening centers in order to leverage the
information contained in each of the individual ones. This is espe-
cially important for rare diseases as the number of cases in each
screening center is relatively low.
If mathematical models would be used in practice to support
diagnostic decision making, several requirements need to be met.
In case of MCADD, no false negatives should occur as experts are
currently able to identify all MCADD cases. A decision support sys-
tem that would fail to identify an MCADD case is therefore unac-
ceptable from a medical point of view. In that respect, decision
trees seem to have less interesting properties for predicting
MCADD. Their higher susceptibility to parameter settings and
random variations in the dataset, combined with a sensitivity well
below 100% make them a less reliable method compared to logistic
regression in the context of MCADD classiﬁcation. Ensemble
methods such as random forests could possibly reduce these unde-
sirable properties, however at the cost of interpretability of the
model.wn in models A–D: the best decision tree model (A); the best logistic regression model
rall best model, namely a ridge logistic regression model (D). The variable set shows
was used for training the model, is also shown between brackets (see also Table 1). The
idation setting for all models, which is the expected performance on unseen data. The
size of the dataset used for training the models (values in brackets indicate the number
nalyses, the values in italics for models A–D are measured on our independent test set.
t state-of–the-art for decision trees (E), logistic regression (F) and feature construction
l logistic regression without threshold optimization on the non-derivatized dataset of
e to those of models A–D, as different datasets were used for the analyses. Used
per leaf, FADJ: adjustment factor, k: ridge parameter of the logistic regression.
s, such that it represents the PPV of an actual population with an MCADD prevalence
atasets and thus require no adjustment.
Fig. 3. Log-concentration of C8 acylcarnitines for MCADD cases (red diamonds) and
normal cases (black circles). (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
T. Van den Bulcke et al. / Journal of Biomedical Informatics 44 (2011) 319–325 3255. Conclusions
We have applied the ﬁrst data mining methods for modeling
MCAD deﬁciency using non-derivatized tandem MS datasets. Three
different data mining methods were evaluated for a broad range of
model parameters, namely decision trees, logistic regression and
ridge logistic regression. The best performing model is a ridge lo-
gistic regression model that shows a signiﬁcantly better perfor-
mance compared to the current state of the art for the derivatized
screening method while retaining more interpretability and
requiring a lower number of acylcarnitine measurements. A
sensitivity of 100%, a speciﬁcity of 99.987% and a positive predic-
tive value of 33.90% (recalibrated for a real population) were
achieved in a stratiﬁed cross-validation setting for non-derivatized
screening data, outperforming current state-of-the-art methods for
MCADD prediction on derivatized data. Our analysis was per-
formed on a relatively small dataset of 44,159 cases with 12
MCADD cases. A further conﬁrmation of these results on larger
derivatized and non-derivatized screening datasets is therefore
desired. The results indicate the potential value of data mining
methods as a diagnostic support tool and show that strong classi-
ﬁcation performances are achieved for non-derivatized tandemMS
data using a method that combines ridge logistic regression with
variable selection and threshold optimization.
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